ERIC ADAMS: Open Payments
NPI 1427719699 · LIBERTY TOWNSHIP, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$650 in 47 payments from 8 companies in 2025. Trend: 2023 $31 · 2024 $112 · 2025 $650
Food & beverage: $650
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 29 | $316 |
| Supernus Pharmaceuticals, Inc. | 6 | $101 |
| Otsuka America Pharmaceutical, Inc. | 4 | $70 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $63 |
| Neos Therapeutics, LP | 2 | $47 |
| Janssen Pharmaceuticals, Inc | 1 | $20 |
| Neuronetics, Inc. | 1 | $19 |
| Vanda Pharmaceuticals Inc. | 1 | $15 |
Products named: VRAYLAR, Qelbree, CAPLYTA, Adzenys XR-ODT, REXULTI, ABILIFY MAINTENA, SPRAVATO, NEUROSTAR TMS THERAPY SYSTEM.
Industry payments across OH — which companies pay providers there.
